Diabetes plays key role in the emergence and expansion of antibiotic resistance

Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their dependability has waned...

Research links high pollen exposure to increased death rates in older adults

As climate change intensifies pollen seasons across the country, new research from the University of Michigan reveals a...

Fruit fly study reveals key brain proteins that help prevent seizures

One in ten people will have at least one seizure in their life, but effective treatments for seizures...

Neuroimmune Mechanisms of Allergic Diseases and Depression: From Cytokine Cascade to Clinical Treatment Protocols

The relationship between allergic diseases and depression extends far beyond simple comorbidity, representing a fundamental neurobiological connection mediated...

Gut bacteria turn bile acids into allies against cancer

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into...

Growth factor cocktail could reverse deadly effects of anthrax toxin

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But...

Vanderbilt Lung Transplant achieves record-breaking 99 procedures in 2024

Surgeons and teams with Vanderbilt Lung Transplant performed 99 lung transplants in 2024, the most ever in one...

New human antibody shows promise for Ebola virus treatment

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human...

Current antivirals not successful in treating severe H5N1 bird flu infections

As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus's threat to human...

T cells play key role in protecting children from severe dengue

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a...

How your diet and probiotics can improve vaccine effectiveness

Could your gut bacteria decide how well vaccines work? A new study reveals how diet and probiotics could...

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature...

Social media and peer pressure fueling dangerous drug misuse

Social media trends and peer pressure can be a dangerous combination to your children and their friends, especially...

Early exposure to food allergens could prevent severe reactions in children

A review in Clinical & Experimental Allergy concludes that exposing young children to small amounts of foods that...

Scientists engineer promising vaccine target for Lyme disease

Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects...

Daily peanut doses help adults overcome severe allergies

The first clinical trial to test whether adults allergic to peanuts can be desensitized has shown great success...

Researchers develop mouse model to study neutrophilic asthma

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative...

Scientists discover key molecular switch for blood stem cell regeneration

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which...

Synthetic microbiome therapy offers new hope against C. difficile infections

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously...

Increased allergy symptoms tied to changing climate patterns

A review published in The Laryngoscope indicates that climate change's effects on pollen seasons and concentrations are contributing...

Influenza A virus changes shape to evade immune responses

Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to infect cells depending on environmental conditions, according to a new study from National Institutes of Health (NIH) scientists. This previously unrecognized response could help explain how influenza A and other viruses persist in populations, evade immune responses, and acquire adaptive mutations, the researchers explain in a new study published in Nature Microbiology.

The study, led by intramural researchers at NIH's National Institute of Allergy and Infectious Diseases (NIAID), was designed to determine why many influenza A virus particles exist as filaments. The filament shape requires more energy to form than a sphere, they state, and its abundance has been previously unexplained. To find the answer, they developed a way to observe and measure real-time influenza A virus structure during formation.

The researchers found: 

  • Influenza A viruses rapidly adjust their shape when placed in conditions that reduce infection efficiency, such as the presence of antiviral antibodies or host incompatibility.
  • A virus' shape is dynamic and impacted by its environment, rather than being fixed by strain, as commonly believed. 
  • The study assessed 16 different virus-cell combinations that resulted in predictable shape trends.

Prior experiments by the research team showed that influenza A virus filaments can resist inactivation by antibodies, and the team is working to understand exactly how antibodies influence shape and infection efficiency. They also anticipate learning how viral mutations affect the shape of the virus. Many other viruses-such as measles, Ebola, Nipah, Hendra and respiratory syncytial virus-also incorporate a mixed-shape infection strategy, the researchers note.

Source:

NIH/National Institute of Allergy and Infectious Diseases

Journal reference:

Partlow, E. A., et al. (2025). Influenza A virus rapidly adapts particle shape to environmental pressures. Nature Microbiology. doi.org/10.1038/s41564-025-01925-9.


Source: http://www.news-medical.net/news/20250210/Influenza-A-virus-changes-shape-to-evade-immune-responses.aspx

Inline Feedbacks
View all comments
guest